Abstract | PURPOSE: The purpose of the study was to evaluate the effect on visual function of orally administered CDP-choline in addition to patching for the treatment of amblyopia in children. METHODS: This was an open label parallel group study comparing patching plus oral CDP-choline with patching alone. Sixty-one participants (aged between 5 and 10 years) suffering from anisometropic or strabismic amblyopia were divided at random into two groups: Group A, 800 or 1,200 mg (according to the body weight) of orally administered CDP-choline and 2-h patching a day; Group B, 2-h patching a day. Both groups were treated for 30 consecutive days. A follow-up visit was set 60 days after the treatment was discontinued. The main outcome measure was the change in visual acuity of amblyopic eyes as measured by Snellen's E charts. The secondary outcome measures were changes in the visual acuity of amblyopic eye as measured by isolated letters (Snellen's E) and changes in the contrast sensitivity of amblyopic eyes. RESULTS: The addition of CDP-choline to patching therapy was not found to be more effective than patching alone after 30-day treatment. The present results showed that adding CDP-choline to patching stabilised the effects obtained during the treatment period. In fact, whereas the participants treated only with patching showed a decrease in visual acuity at 90 days, these receiving CDP-choline and patching combined appeared to maintain the results obtained (two-way ANOVA: P = 0.0042). Similar results were obtained when measuring visual acuity by isolated Snellen's E letters. CONCLUSIONS: In amblyopic patients, CDP-choline combined with patching contributes to obtaining more stable effects than patching alone.
|
Authors | Michela Fresina, Anna Dickmann, Annabella Salerni, Fabio De Gregorio, Emilio C Campos |
Journal | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
(Graefes Arch Clin Exp Ophthalmol)
Vol. 246
Issue 1
Pg. 143-50
(Jan 2008)
ISSN: 1435-702X [Electronic] Germany |
PMID | 17638004
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytidine Diphosphate Choline
|
Topics |
- Administration, Oral
- Amblyopia
(physiopathology, therapy)
- Child
- Child, Preschool
- Combined Modality Therapy
- Cytidine Diphosphate Choline
(administration & dosage)
- Female
- Humans
- Male
- Sensory Deprivation
- Visual Acuity
(physiology)
|